Sp-Gillcin (177鈥?89)

General Information


DRACP ID  DRACP04546

Peptide Name   Sp-Gillcin (177鈥?89)

Sequence  KKRRCFFRHIYVA

Sequence Length  13

UniProt ID  A0A8T9DLA8 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C80H126N26O15S

Absent amino acids  DEGLMNPQSTW

Common amino acids  R

Mass  193832

Pl  11.58

Basic residues  6

Acidic residues  0

Hydrophobic residues  5

Net charge  6

Boman Index  -4265

Hydrophobicity  -55.38

Aliphatic Index  60

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36061863

Title  A truncated peptide Spgillcin177-189 derived from mud crab Scylla paramamosain exerting multiple antibacterial activities

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20539

DRACP is developed by Dr.Zheng's team.